Skip to main content
. Author manuscript; available in PMC: 2013 Feb 13.
Published in final edited form as: Gynecol Oncol. 2009 Sep 22;115(3):362–366. doi: 10.1016/j.ygyno.2009.08.028

Table 1.

Tumor characteristics and mean platinum uptake, by dose group

Drug Dose, mg/kg No. tumors analyzed Median no. tumors per mouse(range) Median tumor length in mm(range) Median tumor width in mm(range) Mean tumor volume in mm3(95% CI)* Mean tumor wet weight in mg(95% CI)* Mean tumor platinum in ng Pt/mg tumor weight(95% CI)*
DDP 10 129a 19.0 (2–23) 4 (2–11) 3 (2–10) 16.2 (11.5–22.8) 15.1 (12.3–18.6) 1.92 (0.85, 4.32)
CBDCA 12.4 384b 34.0 (1–60) 4 (2–22) 3 (1–12) 14.0 (10.8–18.1) 16.6 (14.3–19.3) 0.57 (0.29, 1.11)
CBDCA 85 236c 18.5 (6–45) 4 (1–20) 2 (1–9) 10.3 (7.8–13.5) 16.2 (13.8–19.0) 2.47 (1.28, 4.79)
a

n=9 mice,

b

n=12 mice,

c

n=12 mice,

*

=p>0.05, DDP=cisplatin, CBDCA=carboplatin, Pt=platinum.

Means and standard errors were calculated from log-transformed data using a random intercept model; values reported here are exponentiated model estimates and so estimate the geometric mean.